Preclinical evaluation of recombinant human IFNα2b-containing magnetoliposomes for treating hepatocellular carcinoma
Hui Ye,1,2 Jiansong Tong,2 Jianzhang Wu,3 Xia Xu,4 Shenjie Wu,5 Botao Tan,6 Mengjing Shi,5 Jianguang Wang,1 Weibo Zhao,5 Heng Jiang,5 Sha Jin5 1School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, People’s Republic of China; 2Department of Cellular and Molecular Biology...
Guardado en:
Autores principales: | Ye H, Tong JS, Wu JZ, Xu X, Wu SJ, Tan BT, Shi MJ, Wang JG, Zhao WB, Jiang H, Jin S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d8010bf037184188a1483eb2a4c97774 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting tumor cells and neovascularization using RGD-functionalized magnetoliposomes
por: Garcia Ribeiro RS, et al.
Publicado: (2019) -
In situ precipitation: a novel approach for preparation of iron-oxide magnetoliposomes
por: Xia S, et al.
Publicado: (2014) -
Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis
por: Yan C, et al.
Publicado: (2013) -
Optimization of Magneto-thermally Controlled Release Kinetics by Tuning of Magnetoliposome Composition and Structure
por: Behzad Shirmardi Shaghasemi, et al.
Publicado: (2017) -
Magnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy
por: Irina S. R. Rio, et al.
Publicado: (2021)